Scarica l'app Stockscreener
0.8201
0.99%
-0.0082
Filana Therapeutics Inc Borsa (FLNA) Ultime notizie
Filana (FLNA) Earnings Snapshot: The EPS Result Is Above Expectation in Latest Trading; After Results: The Market Price Declines 3.72% for the Current SessionMargin Compression Risk - vinanet.vn
Filana Therapeutics, Inc. (NASDAQ: FLNA) Share Price, FLNA Stock News, FLNA Share Price & Updates - Kalkine
Filana Therapeutics, Inc.: Revenue and Earnings Analysts Forecasts Revisions | PX91 | US14817C1071 - marketscreener.com
Cassava Sciences Securities Litigation Ruling: Court Denies Ugarte Dismissal Motions Without Prejudice While Awaiting Fifth Circuit Ruling - TipRanks
Law firm investigates Filana Therapeutics officers for possible shareholder rights breaches - Pluang
Did Filana Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
FLNA Q3 2025 Earnings: Narrower Loss Beats Estimates by 20.12% as Shares Dip 2.58%Earnings Manipulation Risk - vinanet.vn
FLNA Q3 2025 Earnings: Narrower-than-Expected Loss Delivers Positive SurpriseEarnings Per Share - vinanet.vn
Filana Therapeutics (FLNA) Climbs 3.75% as Micro-Cap Biotech Approaches Key Resistance at $1.04Volatility Smile - dars.gov.et
Filana Therapeutics (FLNA) Slides 3.3% to $1.00 as Small-Cap Biotech Approaches Key SupportRisk Reversal - vinanet.vn
Weekly Recap: FDA clinical hold on TSC trial and Q2 2026 cash $82.7M - TradingView
FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Lifts Shares 5.21%Low Estimate Range - vinanet.vn
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update - GlobeNewswire
Filana Therapeutics Q2 EPS beats estimate, loss narrows 81% - scanx.trade
Filana Therapeutics Faces Pressure as Shares Slide 4.43%Support at $0.85 in FocusIV Spike - vinanet.vn
Filana Therapeutics, Inc. Revenue Breakdown – NASDAQ:FLNA - TradingView
Filana Therapeutics (FLNA) AGM 2026 Summary - Quartr
Filana Therapeutics (FLNA) Q4 2025 earnings summary - Quartr
Filana Therapeutics (FLNA) Slides 5% as Bearish Momentum Builds; Key Support at $1.04 in FocusATR Stop - dars.gov.et
MSN Money - MSN
FLNA Price Today: Filana Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Despite Stock SlideEPS Surprise History - dars.gov.et
Filana Therapeutics (FLNA) Surges 4.8% as Biotech Momentum BuildsBPI Bear Correction - dars.gov.et
FLNAFilana Therapeutics Inc Short Interest - Finviz
FLNA Should I Buy - Intellectia AI
Price to sales forward of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Price to book forward of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Filana Therapeutics, Inc. Actuals & Estimates (NASDAQ:FLNA) - TradingView
Filana Therapeutics, Inc. Actuals & Estimates (TRADEGATE:PX91) - TradingView
Enterprise value to revenue forward of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
Price to earnings forward of Filana Therapeutics, Inc. – NASDAQ:FLNA - TradingView
FLNA Forecast — Price Target — Prediction for 2027 - TradingView
SGMOQ Stock Price and Chart — OTC:SGMOQ - TradingView
Filana Therapeutics (FLNA) Holds Near Support Amid Modest DeclinePrice Surge Stocks - dars.gov.et
Filana Therapeutics Shareholders Back Board, Compensation Plans - The Globe and Mail
FLNA Q3 2025 Earnings: Narrower Loss Beats Street, But Shares Slide on UncertaintyLow Estimate Range - newsline.com
FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Highlights Operational DisciplineEarnings Trend Analysis - newsline.com
Filana Therapeutics, Inc. 8-K Filing Details: Amended 2018 Omnibus Incentive Plan and Company Information (June 2026) – Minichart - Minichart
Filana Therapeutics (FLNA) investors back directors, plan changes and auditor - Stock Titan
Filana Therapeutics (FLNA) Slips 4.6% as Biotech Sector Headwinds Test SupportConversion Trade - newsline.com
FLNA: All proposals passed as the company focuses on resolving the FDA clinical hold for its TSC program - TradingView
Filana Therapeutics (FLNA) Surges Over 8%—Testing Key Resistance at $1.50Beta Neutral Pair - newsline.com
Filana Therapeutics (FLNA) Edges Higher as Stock Tests Key Resistance LevelTrend Following Picks - newsline.com
Filana Therapeutics (FLNA) Slips 4.5% as Stock Approaches Key Support LevelIV Rank - newsline.com
Data I/O And 2 Other Promising Penny Stocks To Watch - simplywall.st
FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Drives Stock RallyEarnings Surprise Stocks - The Legal Advocate
FLNA Q3 2025 Earnings: Narrower-Than-Expected Loss Propels Shares HigherEarnings Volatility Report - dars.gov.et
Filana Therapeutics (FLNA) Gains 6.38% as Biotech Momentum BuildsPCR Spike - newsline.com
FLNA Reinstated by Maxim Group -- Price Target Announced at $5.0 - GuruFocus
FLNA Reinstated by Maxim Group -- Price Target Announced at $5.00 - GuruFocus
Filana Therapeutics (FLNA) Posts Modest Gains Amid Broader Biotech ResilienceExpert Breakout Alerts - Newser
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):